NIRVF (Nirvana Life Sciences) 12-1 Month Momentum %: -4.00% (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nirvana Life Sciences 12-1 Month Momentum %?

Nirvana Life Sciences NIRVF 12-1 Month Momentum % is -4.00% as of Sep. 16, 2026. The stock has 3 warning signs investors should review. Among 1,355 Biotechnology companies, Nirvana Life Sciences ranks worse than 86.35% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-16), Nirvana Life Sciences's 12-1 Month Momentum % is -4.00%.

The industry rank for Nirvana Life Sciences's 12-1 Month Momentum % or its related term are showing as below:

NIRVF's 12-1 Month Momentum % is ranked worse than
86.35% of 1355 companies
in the Biotechnology industry
Industry Median: -20.02 vs NIRVF: -4.00

Nirvana Life Sciences  (OTCPK:NIRVF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Nirvana Life Sciences 12-1 Month Momentum % Related Terms

NIRVF vs VRTX, REGN, MRNA: 12-1 Month Momentum % Comparison

For the Biotechnology subindustry, Nirvana Life Sciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences 12-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's 12-1 Month Momentum % falls into.


Nirvana Life Sciences  (OTCPK:NIRVF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -4.00% mean?
Nirvana Life Sciences (NIRVF) has a 12-1 Month Momentum % of -4.00% as of Sep. 16, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Nirvana Life Sciences and its competitors. According to the industry distribution chart, Nirvana Life Sciences ranks #1170 out of 1355 companies in the Biotechnology industry, placing it in the top 86.3%.
Is Nirvana Life Sciences' 12-1 Month Momentum % too high?
Nirvana Life Sciences' current 12-1 Month Momentum % is -4.00%. Based on the distribution chart, Nirvana Life Sciences ranks #1170 out of 1355 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Nirvana Life Sciences' 12-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nirvana Life Sciences ranks #1170 out of 1355 companies for 12-1 Month Momentum %. This places Nirvana Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Biotechnology company?
A good 12-1 Month Momentum % depends on the Biotechnology industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current 12-1 Month Momentum % is -4.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current 12-1 Month Momentum % of -4.00%. The current 12-1 Month Momentum % is -4.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current 12-1 Month Momentum % is -4.00% as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.